SCICLONE PHARMACEUTICALS INC Stock-Based Compensation
SCICLONE PHARMACEUTICALS INC reported Stock-Based Compensation of $100.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2014-03-17
- SCICLONE PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2013 was $100.00K, a 75.00% decline from fiscal 2012.
- SCICLONE PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2012 was $400.00K, a 0.00% change from fiscal 2011.
- SCICLONE PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2011 was $400.00K, a 33.33% increase from fiscal 2010.
- SCICLONE PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2010 was $300.00K.
| Period end | Share-based Payment Arrangement, Expense 12 month |
|---|---|
| 2013-12-31 | $100.00K 10-K · filed 2014-03-17 |
| 2012-12-31 | $400.00K 10-K · filed 2014-03-17 |
| 2011-12-31 | $400.00K 10-K · filed 2014-03-17 |
| 2010-12-31 | $300.00K 10-K · filed 2013-04-01 |